Skip to main content
SpringerLink
Log in

Current and potential roles of ghrelin in clinical practice

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Ghrelin is a novel GH-releasing peptide, which has been identified as an endogenous ligand for GH-secretagogue receptor. Ghrelin is mainly secreted by the stomach and plays a critical role in a variety of physiological processes including endocrine, metabolic, cardiovascular, immunological, and other actions. Ghrelin stimulates food intake via hypothalamic neurons and causes a positive energy balance and body weight gain by decreasing fat utilization and promoting adiposity. Given the multiple effects of ghrelin, its potential clinical applications have been evaluated in various conditions. Preliminary trials have shown that it may prove valuable in the management of diseaseinduced cachexia. Ghrelin may improve the wasting syndrome through GH-dependent or GH-independent effects. Moreover, ghrelin may play a role in the management of disorders of gut motility and obesity. Finally, other potential clinical applications of ghrelin include the treatment of patients with diabetes mellitus, infections, rheumatological diseases or GH deficiency and the diagnosis of this hormonal disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Locatelli V, Torsello A. Growth hormone secretagogues: focus on the growth hormone releasing peptides. Pharmacol Res 1997, 36: 415–23.

    PubMed  CAS  Google Scholar 

  2. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000, 279: 909–13.

    PubMed  CAS  Google Scholar 

  3. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001, 86: 4753–8.

    PubMed  CAS  Google Scholar 

  4. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346: 1623–30.

    PubMed  Google Scholar 

  5. Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 2003, 278: 64–70.

    PubMed  CAS  Google Scholar 

  6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656–60.

    PubMed  CAS  Google Scholar 

  7. Deghenghi R, Cananzi MM, Torsello A, Battisti C, Muller EE, Locatelli V. GH-releasing activity of hexarelin. A new growth hormone releasing peptide, in infants and adult rats. Life Sci 1994, 54: 1321–8.

    CAS  Google Scholar 

  8. Smith RG, Cheng K, Schoen WR, Pong SS, Hickey G, Jacks T. A nonpeptidyl growth hormone secretagogue. Science 1993, 260: 1640–3.

    PubMed  CAS  Google Scholar 

  9. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273: 974–7.

    PubMed  CAS  Google Scholar 

  10. Akamizu T, Kangawa K. Emerging results of anticatabolic therapy with ghrelin. Curr Opin Clin Nutr Metab Care 2007, 10: 278–83.

    PubMed  CAS  Google Scholar 

  11. Higgins SC, Gueorguiev M, Korbonits M. Ghrelin, the peripheral hunger hormone. Ann Med 2007, 39: 116–36.

    PubMed  CAS  Google Scholar 

  12. Korbonits M, Grossman AB. Ghrelin: update on a novel hormonal system. Eur J Endocrinol 2004, 151 (Suppl 1): S67–70.

    PubMed  CAS  Google Scholar 

  13. Hosoda H, Kojima M, Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 2006, 100: 398–410.

    PubMed  CAS  Google Scholar 

  14. Arvat E, Vito L, Broglio F, et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000, 23: 493–5.

    PubMed  CAS  Google Scholar 

  15. Hataya Y, Akamizu T. Takaya K, et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001, 86: 4552.

    PubMed  CAS  Google Scholar 

  16. Kok P, Paulo RC, Cosma M, et al. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women. J Clin Endocrinol Metab 2008, 93: 4020–6.

    PubMed Central  PubMed  CAS  Google Scholar 

  17. Messini C, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Growth hormone and prolactin response to ghrelin during the normal menstrual cycle. Clin Endocrinol (Oxf) 2009, 71: 383–7.

    CAS  Google Scholar 

  18. Tena-Sempere M. Exploring the role of ghrelin as novel regulator of gonadal function. Growth Horm IGF Res 2005, 15: 83–8.

    PubMed  CAS  Google Scholar 

  19. Arvat E, Maccario M, Di Vito L, et al. Endocrine activities of ghrelin, a natural GH secretagogue, in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001, 86: 1169–74.

    PubMed  CAS  Google Scholar 

  20. Kluge M, Schussler P, Uhr M, Yassouridis A, Steiger A. Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab 2007, 92: 3202–5.

    PubMed  CAS  Google Scholar 

  21. Lanfranco F, Bonelli L, Baldi M, Me E, Broglio F, Ghigo E. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotrophin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis. J Clin Endocrinol Metab 2008, 93: 3633–9.

    PubMed  CAS  Google Scholar 

  22. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle. Hum Reprod 2009, 24: 976–81.

    PubMed  CAS  Google Scholar 

  23. Nagaya N, Kojima M, Kangawa K. Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern Med 2006, 45: 127–34.

    PubMed  Google Scholar 

  24. Veldhuis JD, Reynolds GA, Iranmanesh A, Bowers CY. Twenty-four hour continuous ghrelin infusion augments physiologically pulsatile, nycthemeral, and entropie (feedback-regulated) modes of growth hormone secretion. J Clin Endocrinol Metab 2008, 93: 3597–603.

    PubMed Central  PubMed  CAS  Google Scholar 

  25. Toshinai K, Mondai MS, Nakazato M, et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001, 281: 1220–5.

    PubMed  CAS  Google Scholar 

  26. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50: 1714–9.

    PubMed  CAS  Google Scholar 

  27. Ravussin E, Tschop M, Morales S, Bouchard C, Heiman ML. Plasma ghrelin concentration and energy balance: overfeeeding and negative energy balance studies in twins. J Clin Endocrinol Metab 2001, 86: 4547–51.

    PubMed  CAS  Google Scholar 

  28. Sugino T, Hasegawa Y, Kikkawa Y, et al. A transient ghrelin surge occurs just before feeding in a scheduled meal-fed sheep. Biochem Biophys Res Commun 2002, 295: 255–60.

    PubMed  CAS  Google Scholar 

  29. Brunetti L, Recinella L, Orlando G, Michelotto B, Di Nisio C, Vacca M. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol 2002, 454: 189–92.

    PubMed  CAS  Google Scholar 

  30. Drazen DL, Vahl TP, D’Alessio DA, Seeley RJ, Woods SC. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 2006, 147: 23–30.

    PubMed  CAS  Google Scholar 

  31. Iqbal J, Kurose Y, Canny B, Clarke IJ. Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and Cortisol secretion in sheep. Endocrinology 2006, 147: 510–9.

    PubMed  CAS  Google Scholar 

  32. Egecioglu E, Bjursell M, Ljungberg A, et al. Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am J Physiol Endocrinol Metab 2006, 290: E317–25.

    PubMed  CAS  Google Scholar 

  33. Matsuda K, Miura T, Kaiya H, et al. Stimulatory effect of n-octanoylated ghrelin on locomotor activity in the goldfish. Carassius auratus. Peptides 2006, 27: 1335–40.

    CAS  Google Scholar 

  34. Tang-Christensen M, Vrang N, Ortmann S, Bidlingmaier M, Horvath TL, Tschöp M. Central administration of ghrelin and agouti-related protein (83–132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 2004, 145: 4645–52.

    PubMed  CAS  Google Scholar 

  35. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin — a hormone with multiple functions. Front Neuroendocrinol 2004, 25: 27–68.

    PubMed  CAS  Google Scholar 

  36. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000, 407: 908–13.

    PubMed  CAS  Google Scholar 

  37. Muccioli G, Pons N, Ghe C, Catapano F, Granata R, Ghigo E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 2004, 498: 27–35.

    PubMed  CAS  Google Scholar 

  38. Yasuda T, Masaki T, Kakuma T, Yoshimatsu H. Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats. Neurosci Lett 2003, 349: 75–8.

    PubMed  CAS  Google Scholar 

  39. Gauna C, Delhanty PJ, Hofland LJ, et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 2005, 90: 1055–60.

    PubMed  CAS  Google Scholar 

  40. Nakagawa E, Nagaya N, Okumura H, et al. Hyperglycemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose. Clin Sci (Lond) 2002, 103: 325–8.

    CAS  Google Scholar 

  41. Solomon TP, Chambers ES, Jeukendrup AE, Toogood AA, Blannin AK. The effect of feeding frequency on insulin and ghrelin responses in human subjects. Br J Nutr 2008, 100: 810–9.

    PubMed  CAS  Google Scholar 

  42. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50: 707–9.

    PubMed  Google Scholar 

  43. Wortley KE, Anderson KD, Garcia K, et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004, 101: 8227–32.

    PubMed Central  PubMed  CAS  Google Scholar 

  44. Kirchner H, Gutierrez J, Solenberg P, et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009, 15: 741–5.

    PubMed Central  PubMed  CAS  Google Scholar 

  45. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 1964, 271: 403–9.

    PubMed  CAS  Google Scholar 

  46. Levine B, Kaiman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323: 236–41.

    PubMed  CAS  Google Scholar 

  47. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance in cardiac cachexia. Circulation 1997, 96: 526–34.

    PubMed  CAS  Google Scholar 

  48. Debigaré R, Marquis K, Côté CH, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003, 124: 83–9.

    PubMed  Google Scholar 

  49. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997, 349: 1050–3.

    PubMed  CAS  Google Scholar 

  50. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160: 1856–61.

    PubMed  CAS  Google Scholar 

  51. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002, 52: 72–91.

    PubMed  Google Scholar 

  52. DeBoer MD. Melanocortin interventions in cachexia: how soon from bench to bedside? Curr Opin Clin Nutr Metab Care 2007, 10: 457–62.

    PubMed  CAS  Google Scholar 

  53. DeVriese C, Delporte C. Influence of ghrelin on food intake and energy homeostasis. Curr Opin Clin Nutr Metab Care 2007, 10: 615–9.

    CAS  Google Scholar 

  54. Garcia JM, Garcia-Touza M, Hijazi RA, et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 2005, 90: 2920–8.

    PubMed  CAS  Google Scholar 

  55. Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A. Anti-inflammatory effect of the ghrelin agonist growth hormonereleasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 2005, 288: 486–92.

    Google Scholar 

  56. Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A. Ghrelin receptor agonist GHRP-2 prevents arthritis — induced increase in E3 ubiquitin-ligating enzymes MURF1 and MAEbx gene expression in skeletal muscle. Am J Physiol Endocrinol Metab 2005, 289: E1007–14.

    PubMed  CAS  Google Scholar 

  57. Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004, 110: 3674–9.

    PubMed  CAS  Google Scholar 

  58. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002, 85: 51–66.

    PubMed  Google Scholar 

  59. Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001, 104: 2034–8.

    PubMed  CAS  Google Scholar 

  60. Nagaya N, Miyatake K, Uematsu M, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab 2001, 86: 5854–9.

    PubMed  CAS  Google Scholar 

  61. Nagaya N, Kojima M, Uematsu M, et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol 2001, 280: R1483–7.

    CAS  Google Scholar 

  62. Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 2002, 136: 1146–52.

    PubMed Central  PubMed  CAS  Google Scholar 

  63. Matsumura K, Tsuchihashi T, Fujii K, Abe I, Iida M. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 2002, 40: 694–9.

    PubMed  CAS  Google Scholar 

  64. Baldanzi G, Filigheddu N, Cutrupi S, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002, 159: 1029–37.

    PubMed Central  PubMed  CAS  Google Scholar 

  65. Ergün P, Turay UY, Aydogdu M, et al. Nutritional status of COPD patients with acute exacerbation. Tuberk Toraks 2003, 51: 239–43.

    PubMed  Google Scholar 

  66. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000, 94: 859–67.

    PubMed  CAS  Google Scholar 

  67. Takabatake N, Nakamura H, Minamihaba O, et al. A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability. Am J Respir Crit Care Med 2001, 163: 1314–9.

    PubMed  CAS  Google Scholar 

  68. Matsumura T, Nakayama M, Satoh H, Naito A, Kamahara K, Sekizawa K. Plasma orexin-A levels and body composition in COPD. Chest 2003, 123: 1060–5.

    PubMed  CAS  Google Scholar 

  69. Debigaré R, Marquis K, Côté CH, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003, 124: 83–9.

    PubMed  Google Scholar 

  70. Eid AA, lonescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164: 1414–8.

    PubMed  CAS  Google Scholar 

  71. Foley RJ, ZuWallack R. The impact of nutritional depletion in chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001, 21: 288–95.

    PubMed  CAS  Google Scholar 

  72. Agust AG, Gari PG, Sauleda J, Busquets X. Weight loss in chronic obstructive pulmonary disease. Mechanisms and implications. Pulm Pharmacol Ther 2002, 15: 425–32.

    CAS  Google Scholar 

  73. Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting JW. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease: a prospective, randomized, controlled study. Am J Respir Crit Care Med 1997, 156: 1800–6.

    PubMed  CAS  Google Scholar 

  74. Itoh T, Nagaya N, Yoshikawa M, et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170: 879–82.

    PubMed  Google Scholar 

  75. Luo F-M, Liu X-J, Li S-Q, Wang Z-L, Liu C-T, Yuan Y-M. Circulating ghrelin in patients with chronic obstructive pulmonary disease. Nutrition 2005, 21: 793–8.

    PubMed  CAS  Google Scholar 

  76. Nagaya N, Itoh T, Murakami S, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005, 128: 1187–93.

    PubMed  CAS  Google Scholar 

  77. Neary NM, Small CJ, Wren AM, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004, 89: 2832–6.

    PubMed  CAS  Google Scholar 

  78. Hanada T, Toshinai K, Date Y, et al. Upregulation of ghrelin expression in cachectic nude mice bearing human melanoma cells. Metabolism 2004, 53: 84–8.

    PubMed  CAS  Google Scholar 

  79. Hanada T, Toshinai K, Kajimura N, et al. Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem Biophys Res Commun 2003, 301: 275–9.

    PubMed  CAS  Google Scholar 

  80. Wang W, Andersson M, Iresjö BM, Lönnroth C, Lundholm K. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia. Int J Oncol 2006, 28: 1393–400.

    PubMed  CAS  Google Scholar 

  81. Strasser F, Lutz TA, Maeder MT, et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomized, placebo-controlled, double-blind, double-crossover study. Br J Cancer 2008, 98: 300–8.

    PubMed Central  PubMed  CAS  Google Scholar 

  82. Bruera E. Pharmacological treatment of cachexia: any progress? Support Care Cancer 1998, 6: 109–13.

    PubMed  CAS  Google Scholar 

  83. Bruera E, Belzile M, Neumann C, Harsanyi Z, Babul N, Darke A. A double-blind crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 2000, 19: 427–35.

    PubMed  CAS  Google Scholar 

  84. Lainscak M, Andreas S, Scanlon PD, et al. Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease. Intern Med 2006, 45: 837.

    PubMed  Google Scholar 

  85. Laviano A, Meguid MM, Inui A, et al. Therapy insight: cancer anorexia-cachexia syndrome — when all you can eat is yourself. Nat Clin Pract Oncol 2005, 2: 158–65.

    PubMed  CAS  Google Scholar 

  86. Mehrotra R, Kopple JD. Nutritional management of maintenance dialysis patients: Why aren’t we doing better? Annu Rev Nutr 2001, 21: 343–79.

    PubMed  CAS  Google Scholar 

  87. Kopple JD. Therapeutic approaches to malnutrition in chronic dialysis patients: the different modalities of nutritional support. Am J Kidney Dis 1999, 33: 180–5.

    PubMed  CAS  Google Scholar 

  88. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993, 329: 1001–6.

    PubMed  Google Scholar 

  89. CANUSA. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996, 7: 198–207.

    Google Scholar 

  90. Aguilera A, Cirugeda A, Amair R, et al. Ghrelin plasma levels and appetite in peritoneal dialysis patients. Adv Perit Dial 2004, 20: 194–9.

    PubMed  CAS  Google Scholar 

  91. Wynne K, Giannitsopoulou K, Small CJ, et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 2005, 16: 2111–8.

    PubMed  CAS  Google Scholar 

  92. Ashby DR, Ford HE, Wynne KJ, et al. Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 2009, 76: 199–206.

    PubMed  CAS  Google Scholar 

  93. Monteleone P, Serritella C, Martiadis V, Maj M. Deranged secretion of ghrelin and obestatin in the cephalic phase of vagal stimulation in women with anorexia nervosa. Biol Psychiatry 2008, 64: 1005–8.

    PubMed  CAS  Google Scholar 

  94. Broglio F, Gianotti L, Destefanis S, et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf) 2004, 60: 592–9.

    CAS  Google Scholar 

  95. Miljic D, Pekic S, Djurovic M, et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and Cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab 2006, 91: 1491–5.

    PubMed  CAS  Google Scholar 

  96. Miljic D, Djurovic M, Pekic S, et al. Glucose metabolism during ghrelin infusion in patients with anorexia nervosa. J Endocrinol Invest 2007, 30: 771–5.

    PubMed  CAS  Google Scholar 

  97. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999, 45 (Suppl): II37–42.

    PubMed Central  PubMed  Google Scholar 

  98. Shinomiya T, Fukunaga M, Akamizu T, et al. Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol 2005, 40: 648–53.

    PubMed  CAS  Google Scholar 

  99. Akamizu T, Iwakura H, Ariyasu H, et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol 2008, 158: 491–8.

    PubMed  CAS  Google Scholar 

  100. Kamiji M, Inui A. The role of ghrelin and ghrelin analogues in wasting disease. Curr Opin Clin Nutr Metab Care 2008, 11: 443–51.

    PubMed  CAS  Google Scholar 

  101. Le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR. Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal weight but not obese subjects. J Clin Endocrinol Metab 2005, 90: 1068–71.

    PubMed  Google Scholar 

  102. Geliebter A, Hashim SA, Gluck ME. Appetite-related gut peptides, ghrelin, PYY, and GLP-1 in obese women with and without binge eating disorder (BED). Physiol Behav 2008, 94: 696–9.

    PubMed  CAS  Google Scholar 

  103. Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader-Willi syndrome. Nat Med 2002, 8: 643–4.

    PubMed  CAS  Google Scholar 

  104. DelParigi A, Tschop M, Heiman ML, et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 2002, 87: 5461–4.

    PubMed  CAS  Google Scholar 

  105. Mizia-Stec K, Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, et al. Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment. Endokrynol Pol 2008, 59: 207–11.

    PubMed  Google Scholar 

  106. Inui A, Asakawa A, Bowers CY, et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J2004, 18: 439–56.

  107. Valera Mora ME, Scarfone A, Valenza V, et al. Ghrelin does not influence gastric emptying in obese subjects. Obes Res 2005, 13: 739–44.

    PubMed  Google Scholar 

  108. Asakawa A, Inui A, Kaga T, et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52: 947–52.

    PubMed Central  PubMed  CAS  Google Scholar 

  109. Zorrilla EP, Iwasaki S, Moss JA, et al. Vaccination against weight gain. Proc Natl Acad Sci USA 2006, 103: 13226–31.

    PubMed Central  PubMed  CAS  Google Scholar 

  110. Shearman LP, Wang SP, Helmling S, et al. Ghrelin neutralization by a ribonucleic acid — SPM ameliorates obesity in diet-induced obese mice. Endocrinology 2006, 147: 1517–26.

    PubMed  CAS  Google Scholar 

  111. Holst B, Cygankiewicz A, Jensen TH, et al. High constitutive signaling of the ghrelin receptor–indentification of a potent inverse agonist. Mol Endocrinol 2003, 17: 2201–10.

    PubMed  CAS  Google Scholar 

  112. Holst B, Schwartz TW. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol Sci 2004, 25: 113–7.

    PubMed  CAS  Google Scholar 

  113. Kageyama H, Funahashi H, Hirayama M, et al. Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 2005, 126: 67–71.

    PubMed  CAS  Google Scholar 

  114. Reimer MK, Pacini G, Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 2003, 144: 916–21.

    PubMed  CAS  Google Scholar 

  115. Colombo M, Gregersen S, Xiao J, Hermansen K. Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets. Pancreas 2003, 27: 161–6.

    PubMed  CAS  Google Scholar 

  116. Date Y, Nakazato M, Hashiguchi S, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002, 51: 124–9.

    PubMed  CAS  Google Scholar 

  117. Hosoda H, Kojima M, Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 2006, 100: 398–410.

    PubMed  CAS  Google Scholar 

  118. Dezaki K, Hosoda H, Kakei M, et al. Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in (beta) cells: Implication in the glycemic controls in rodents. Diabetes 2004, 53: 3142–51.

    PubMed  CAS  Google Scholar 

  119. Sun Y, Asnicar M, Saha P, Chan L, Smith R. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006, 3: 379–86.

    PubMed  CAS  Google Scholar 

  120. Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med 2004, 351: 2179–86.

    PubMed  CAS  Google Scholar 

  121. Regan FM, Cutfield WS, Jefferies C, et al. The impact of early nutrition in premature infants on later childhood insulin sensitivity and growth. Pediatrics 2006, 118: 1943–9.

    PubMed  Google Scholar 

  122. Wang X, Liang L, Du L. The effects of intrauterine undernutrition on pancreas ghrelin and insulin expression in neonate rats. J Endocrinol 2007, 194: 121–9.

    PubMed  CAS  Google Scholar 

  123. Zhao H, Liu G, Wang Q, et al. Effect of ghrelin on human endothelial cells apoptosis induced by high glucose. Biochem Biophys Res Commun 2007, 362: 677–81.

    PubMed  CAS  Google Scholar 

  124. Celi F, Bini V, Papi F, et al. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development. Clin Endocrinol (Oxf) 2005, 63: 139–45.

    CAS  Google Scholar 

  125. Martos-Moreno GA, Barrios V, Soriano-Guillen L, Argente J. Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy. Eur J Endocrinol 2006, 155: 757–61.

    PubMed  CAS  Google Scholar 

  126. Pöykkö SM, Kellokoski E, Hörkkö S, Kauma H, Kesöniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003, 52: 2546–53.

    PubMed  Google Scholar 

  127. Asai S, Katabami T, Obi N, et al. No ghrelin response to oral glucose in diabetes mellitus with gastroparesis. Endocr J 2009, 56: 79–87.

    PubMed  CAS  Google Scholar 

  128. Gomez R, Lago F, Gomez-Reino JJ, Gualillo O. Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin. Expert Opinion on Therapeutic Targets 2009, 13: 583–91.

    CAS  Google Scholar 

  129. Wiedmer P, Nogueiras R, Broglio F, D’Alessio D, Tschop MH. Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab 2007, 3: 705–12.

    PubMed  CAS  Google Scholar 

  130. Dezaki K, Sone H, Koizumi M, et al. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat dietinduced glucose intolerance. Diabetes 2006, 55: 3486–93.

    PubMed  CAS  Google Scholar 

  131. Rudolph J, Esler WP, O’Connor S, et al. Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity. J Med Chem 2007, 50: 5202–16.

    PubMed  CAS  Google Scholar 

  132. Esler WP, Rudolph J, Claus TH, et al. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 2007, 148: 5175–85.

    PubMed  CAS  Google Scholar 

  133. Ates Y, Degertekin B, Erdil A, Yaman H, Dagalp K. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. Dig Dis Sci 2008, 53: 2215–21.

    PubMed  CAS  Google Scholar 

  134. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000, 276: 905–8.

    PubMed  CAS  Google Scholar 

  135. Dornonville de la Cour C, Lindström E, Norlén P, Håkanson R. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul Pept 2004, 120: 23–32.

    Google Scholar 

  136. Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 2001, 280: 904–7.

    PubMed  CAS  Google Scholar 

  137. Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001, 145: 669–73.

    PubMed  CAS  Google Scholar 

  138. Cuntz U, Frühauf E, Wawarta R, et al. A role for the novel weight regulating hormone ghrelin in anorexia nervosa. Am Clin Lab 2002, 21: 22–3.

    PubMed  Google Scholar 

  139. Tanaka M, Naruo T, Muranaga T, et al. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 2002, 146: R1–3.

    PubMed  CAS  Google Scholar 

  140. Tebbe JJ, Mronga S, Tebbe CG, Ortmann E, Arnold R, Schafer MK. Ghrelin-induced Stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation. J Neuroendocrinol 2005, 17: 570–6.

    PubMed  CAS  Google Scholar 

  141. Ang D, Nicolai H, Vos R, et al. Influence of ghrelin on the gastric accommondation reflex and on meal-induced satiety in man. Neurogastroenterol Motil 2009, 21: 528–33, e8-9.

    PubMed  CAS  Google Scholar 

  142. Ohno T, Kamiyama Y, Aihara R, et al. Ghrelin does not stimulate gastrointestinal motility and gastric emptying: an experimental study of conscious dogs. Neurogastroenterol Motil 2006, 18: 129–35.

    PubMed  CAS  Google Scholar 

  143. Trudel L, Tomasetto C, Rio MC, et al. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002, 282: G948–52.

    PubMed  CAS  Google Scholar 

  144. Poitras P, Polvino WJ, Rocheleau B. Gastrokinetic effect of ghrelin analog RC-1139 in the rat. Effect on post-operative and on morphine induced ileus. Peptides 2005, 26: 1598–601.

    PubMed  CAS  Google Scholar 

  145. De Winter BY, De Man JG, Seerden TC, et al. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil 2004, 16: 439–46.

    PubMed  Google Scholar 

  146. Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in indiopathic gastroparesis. Aliment Pharmacol Ther 2005, 22: 847–53.

    PubMed  CAS  Google Scholar 

  147. Murray CD, Martin NM, Patterson M, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double-blind placebocontrolled crossover study. Gut 2005, 54: 1693–8.

    PubMed Central  PubMed  CAS  Google Scholar 

  148. Katugampola SD, Pallikaros Z, Davenport AP. [125l-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis. Br J Pharmacol 2001, 134: 143–9.

    PubMed Central  PubMed  CAS  Google Scholar 

  149. Vestergaard ET, Andersen NH, Hansen TK, et al. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. Am J Physiol Heart Circ Physiol 2007, 293: H3020–6.

    PubMed  CAS  Google Scholar 

  150. Henriques-Coelho T, Roncon-Albuquerque Júnior R, Lourenço AP, et al. Ghrelin reverses molecular, structural, and hemodynamic alterations of the right ventricle in pulmonary hypertension. Rev Port Cardiol 2006, 25: 55–63.

    PubMed  Google Scholar 

  151. Tesauro M, Schinzari F, Iantorno M, et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005, 112: 2986–92.

    PubMed  CAS  Google Scholar 

  152. Hattori N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm IGF Res 2009, 19: 187–97.

    PubMed  CAS  Google Scholar 

  153. Wu R, Dong W, Cui X, et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007, 245: 480–6.

    PubMed Central  PubMed  Google Scholar 

  154. Yada T, Kaiya H, Mutoh K, Azuma T, Hyodo S, Kangawa K. Ghrelin stimulates phagocytosis and Superoxide production in fish leukocytes. J Endocrinol 2006, 189: 57–65.

    PubMed  CAS  Google Scholar 

  155. Takeda R, Nishimatsu H, Suzuki E, et al. Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol 2006, 17: 113–21.

    PubMed  CAS  Google Scholar 

  156. Konturek PC, Brzozowski T, Pajdo R, et al. Ghrelin-a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004, 55: 325–36.

    PubMed  CAS  Google Scholar 

  157. Kodama T, Ashitani J, Matsumoto N, Kangawa K, Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm Pharmacol Ther 2008, 21: 774–9.

    PubMed  CAS  Google Scholar 

  158. Vila G, Maier C, Riedl M, et al. Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 2007, 92: 3930–4.

    PubMed  CAS  Google Scholar 

  159. Chorny A, Anderson P, Gonzalez-Rey E, Delgado M. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J Immunol 2008, 180: 8369–77.

    PubMed  CAS  Google Scholar 

  160. Wu R, Dong W, Zhou M, Cui X, Hank Simms H, Wang P. Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc Res 2005, 68: 318–26.

    PubMed  CAS  Google Scholar 

  161. Wu R, Dong W, Zhou M, et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med 2007, 176: 805–13.

    PubMed Central  PubMed  CAS  Google Scholar 

  162. Otero M, Nogueiras R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford) 2004, 43: 306–10.

    CAS  Google Scholar 

  163. Koca SS, Ozgen M, Aydin S, Dag S, Evren B, Isik A. Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation 2008, 31: 329–35.

    PubMed  CAS  Google Scholar 

  164. Toussirot E, Streit G, Nguyen NU, et al. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 2007, 56: 1383–9.

    PubMed  CAS  Google Scholar 

  165. Kümpers P, Horn R, Brabant G, et al. Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology (Oxford) 2008, 47: 484–7.

    Google Scholar 

  166. Jang EJ, Park SW, Park JS, et al. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J Gastroenterol Hepatol 2008, 23 (Suppl 2): S278–85.

    PubMed  CAS  Google Scholar 

  167. de Martel C, HaggertyTD, Corley DA, Vogelman JH, Orentreich N, Parsonnet J. Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol 2007, 102: 1166–72.

    PubMed  Google Scholar 

  168. Fukushima N, Hanada R, Teranishi H, et al. Ghrelin directly regulates bone formation. J Bone Miner Res 2005, 20: 790–8.

    PubMed  CAS  Google Scholar 

  169. Caminos JE, Gualillo O, Lago F, et al. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 2005, 146: 1285–92.

    PubMed  CAS  Google Scholar 

  170. Cassoni P, Allia E, Marrocco T, et al. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptros in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line. J Endocrinol Invest 2006, 29: 781–90.

    PubMed  CAS  Google Scholar 

  171. Cassoni P, Ghé C, Marrocco T, et al. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell line. Eur J Endocrinol 2004, 150: 173–84.

    PubMed  CAS  Google Scholar 

  172. Yeh AH, Jeffery PL, Duncan RP, et al. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res 2005, 11: 8295–303.

    PubMed  CAS  Google Scholar 

  173. Jeffery PL, Herington AC, Chopin LK. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 2002, 172: R7–11.

    PubMed  CAS  Google Scholar 

  174. Cassoni P, Papotti M, Ghé C, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 2001, 86: 1738–45.

    PubMed  CAS  Google Scholar 

  175. Jeffery PL, Murray RE, Yeh AH, et al. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer 2005, 12: 839–50.

    PubMed  CAS  Google Scholar 

  176. Murata M, Okimura Y, Iida K, et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 2002, 277: 5667–74.

    PubMed  CAS  Google Scholar 

  177. Nanzer AM, Khalaf S, Mozid AM, et al. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur J Endocrinol 2004, 151: 233–40.

    PubMed  CAS  Google Scholar 

  178. Duxbury MS, Waseem T, Ito H, et al. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun 2003, 309: 464–8.

    PubMed  CAS  Google Scholar 

  179. Delhanty PJ, van Koetsveld PM, Gauna C, et al. Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an antiapoptotic pathway. Am J Physiol Endocrinol Metab 2007, 293: E302–9.

    PubMed  CAS  Google Scholar 

  180. Leontiou CA, Franchi G, Korbonits M. Ghrelin in neuroendocrine organs and tumours. Pituitary 2007, 10: 213–25.

    PubMed  CAS  Google Scholar 

  181. Volante M, Allia E, Fulcheri E, et al. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. Am J Pathol 2003, 162: 645–54.

    PubMed Central  PubMed  CAS  Google Scholar 

  182. Raghay K, García-Caballero T, Nogueiras R, et al. Ghrelin localization in rat and human thyroid and parathyroid glands and tumours. Histochem Cell Biol 2006, 125: 239–46.

    PubMed  CAS  Google Scholar 

  183. Ekeblad S, Nilsson B, Lejonklou MH, et al. Gastrointestinal stromal tumors express the orexigen ghrelin. Endocr Relat Cancer 2006, 13: 963–70.

    PubMed  CAS  Google Scholar 

  184. D’Onghia V, Leoncini R, Carli R, et al. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother 2007, 61: 137–41.

    PubMed  Google Scholar 

  185. Huang Q, Fan YZ, Ge BJ, et al. Circulating ghrelin in patients with gastric or colorectal cancer. Dig Dis Sci 2007, 52: 803–9.

    PubMed  CAS  Google Scholar 

  186. An JY, Choi MG, Noh JH, et al. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J Surg Res 2007, 143: 344–9.

    PubMed  CAS  Google Scholar 

  187. Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006, 9: 381–8.

    PubMed  CAS  Google Scholar 

  188. Johansson I, Destefanis S, Aberg ND, et al. Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells. Endocrinol 2008, 149: 219–9.

    Google Scholar 

  189. Carvajal P, Carlini VP, Schioth HB, de Barioglio SR, Salvatierra NA. Central ghrelin increases anxiety in the Open Field test and impairs retention memory in a passive avoidance task in neonatal chicks. Neurobiol Learn Mem 2009, 91: 402–7.

    PubMed  CAS  Google Scholar 

  190. Carlini VP, Monzón ME, Varas MM, et al. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun 2002, 299: 739–43.

    PubMed  CAS  Google Scholar 

  191. Jerlhag E, Egecioglu E, Landgren S, et al. Requirement of central ghrelin signaling for alcohol reward. PNAS 2009, 106: 11318–23.

    PubMed Central  PubMed  CAS  Google Scholar 

  192. Szentirmai E, Kapás L, Sun Y, Smith RG, Krueger JM. Spontaneous sleep and homeostatic sleep regulation in ghrelin knockout mice. Am J Physiol Regul Integr Comp Physiol 2007, 293: R510–7.

    Google Scholar 

  193. Tanaka K, Minoura H, Isobe T, et al. Ghrelin is involved in the decidualization of human endometrial stromal cells. J Clin Endocrinol Metab 2003, 88: 2335–40.

    PubMed  CAS  Google Scholar 

  194. Kawamura K, Sato N, Fukuda J, et al. Ghrelin inhibits the development of mouse preimplantation embryos in vitro. Endocrinology 2003, 144: 2623–33.

    PubMed  CAS  Google Scholar 

  195. Fernández-Fernández R, Navarro VM, Barreiro ML, et al. Effects of chronic hyperghrelinemia on puberty onset and pregnancy outcome in the rat. Endocrinology 2005, 146: 3018–25.

    PubMed  Google Scholar 

  196. Hayashida T, Nakahara K, Mondai MS, et al. Ghrelin in neonatal rats: distribution in stomach and its possible role. J Endocrinol 2002, 173: 239–45.

    PubMed  CAS  Google Scholar 

  197. Nakahara K, Nakagawa M, Baba Y, et al. Maternal ghrelin plays an important role in rat fetal development during pregnancy. Endocrinology 2006, 147: 1333–42.

    PubMed  CAS  Google Scholar 

  198. Fuglsang J. Ghrelin in pregnancy and lactation. Vitam Horm 2008, 77: 259–84.

    PubMed  CAS  Google Scholar 

  199. Volante M, Fulcheri E, Allia E, Cerrato M, Pucci A, Papotti M. Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem 2002, 50: 1013–21.

    PubMed  CAS  Google Scholar 

  200. Nunes S, Nogueira-Silva C, Dias E, Moura R, Correia-Pinto J. Ghrelin and obestatin: different role in fetal lung development? Peptides 2008, 29: 2150–8.

    PubMed  CAS  Google Scholar 

  201. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993, 14: 20–39.

    PubMed  CAS  Google Scholar 

  202. Wurtman JJ, Lieberman H, Tsay R, et al. Calorie and nutrient intakes of elderly and young subjects measured under identical conditions. J Gerontol 1988, 43: B174–80.

    PubMed  CAS  Google Scholar 

  203. Morley JE. Anorexia of aging: physiologic and pathologic. Am J Clin Nutr 1997, 66: 760–73.

    PubMed  CAS  Google Scholar 

  204. Müller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol Rev 1999, 79: 511–607.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Dept., University Hospital of Larissa, Mezourlo, Larissa, 41110, Hellas

    G. Angelidis, V. Valotassiou & P. Georgoulias

Authors
  1. G. Angelidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Valotassiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Georgoulias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Georgoulias.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angelidis, G., Valotassiou, V. & Georgoulias, P. Current and potential roles of ghrelin in clinical practice. J Endocrinol Invest 33, 823–838 (2010). https://doi.org/10.1007/BF03350350

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350350

Key-words

Search

Navigation